At Rophevac, our Research & Development is at the heart of everything we do. We are committed to pioneering innovative genomic solutions that transform healthcare and improve patient outcomes across India and globally.
Transforming healthcare through genomics and personalized medicine approaches
Transforming healthcare through genomics and personalized medicine approaches based on individual genetic profiles.
Learn MorePioneering breakthrough technologies in genomics and molecular biology
Comprehensive genomic analysis using whole genome sequencing, exome sequencing, and targeted sequencing approaches.
Learn MoreCell-type specific analysis revealing tumor heterogeneity, immune profiling, and disease mechanisms at single-cell resolution.
Learn MoreDNA methylation and chromatin accessibility analysis for cancer classification, biomarker discovery, and gene regulation studies.
Learn MoreProtein expression profiling and metabolic pathway analysis for functional validation and biomarker discovery.
Learn MoreNon-invasive cancer detection and monitoring using circulating tumor DNA, CTCs, and extracellular vesicles.
Learn MoreCRISPR/Cas9 technology, high-throughput screening, and organoid models for target validation and disease modeling.
Learn MoreGene expression and protein localization in tissue context for tumor microenvironment and disease progression studies.
Learn MoreHarnessing artificial intelligence and machine learning for genomic insights
Machine learning on multi-omic datasets for target identification, protein structure prediction, and in silico validation.
Learn MoreAutomated variant classification using VarMiner and OncoMiner platforms with ACMG/AMP guidelines.
Learn MoreMulti-omic integration and predictive biomarkers for treatment response and disease progression.
Learn MoreAI-powered image analysis with quantitative continuous scoring for biomarker assessment and tissue analysis.
Learn MorePatient recruitment, adaptive trial designs, and real-time monitoring using artificial intelligence.
Learn MorePharmacogenomics and cancer treatment selection using AI-driven molecular profiling.
Learn MoreScientific literature mining and clinical note analysis for evidence extraction and phenotype identification.
Learn MoreUnified data platform, cloud computing, machine learning platforms, and bioinformatics tools.
Learn MoreResponsible AI principles, data privacy, and model validation ensuring transparency and fairness.
Learn MoreAccelerating translation from lab to clinic
Accelerating translation from lab to clinic through biomarker-driven studies and diagnostic development.
Learn MoreAdvanced platforms and tools driving discovery
Advanced sequencing platforms including Illumina NovaSeq, NextSeq, Oxford Nanopore, and PacBio.
Learn MoreDigital PCR, qPCR, microarray platforms, and mass spectrometry for comprehensive molecular analysis.
Learn MoreFlow cytometry, digital pathology, and FISH for immunophenotyping and chromosomal analysis.
Learn MoreHigh-performance computing, cloud computing, and petabyte-scale data storage for genomic analysis.
Learn MoreVarMiner, OncoMiner, and BioBank Repository for variant interpretation and sample management.
Learn MoreNext-generation therapeutic approaches based on genomic insights
Synthetic DNA/RNA molecules for gene expression modulation in rare diseases and cancer.
Learn MoreDelivering functional mRNA for protein replacement therapy, vaccines, and regenerative medicine.
Learn MoreViral and non-viral delivery systems for inherited retinal diseases, hemophilia, and genetic disorders.
Learn MoreCRISPR/Cas systems including base editors and prime editors for ex vivo and in vivo gene correction.
Learn MoreCAR-T cell therapy, stem cell therapy, and therapeutic gene editing for cancer and regenerative medicine.
Learn MoreViruses that selectively infect and kill cancer cells while activating the immune system.
Learn MoresiRNA therapeutics for gene silencing in hereditary diseases and metabolic disorders.
Learn MoreGlobal network of innovation hubs and research facilities
Global R&D headquarters with CAP-accredited laboratory and comprehensive genomics capabilities.
Learn MoreAI and machine learning centre with high-performance computing and data science capabilities.
Learn MoreClinical trials, regulatory affairs, and pharmacogenomics research facility.
Learn MorePartnerships with leading institutions in USA, UK, and Europe for joint research and technology transfer.
Learn MoreSpecialized centres for cancer genomics, rare diseases, infectious diseases, and population genomics.
Learn MoreRophevac's R&D operations are focused on advancing genetic testing technologies, developing precision medicine solutions, and creating next-generation diagnostic tools that enable early disease detection, accurate diagnosis, and personalized treatment strategies.
Scientific Publications
Patents Filed
Tests Performed Annually
Revenue in R&D